Fact-checked by Grok 2 weeks ago

Informed Consent Action Network

The (ICAN) is a United States-based non-profit organization founded in 2016 by to investigate the safety profiles of vaccines, pharmaceutical drugs, and medical procedures while promoting the principle of for individuals prior to undergoing such interventions. ICAN employs a strategy centered on Freedom of Information Act (FOIA) requests, legal petitions, and lawsuits against federal agencies including the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and (NIH) to compel the release of data and documentation that regulators are required by law to maintain but often withhold from public scrutiny. Through these efforts, ICAN has secured court-ordered disclosures of previously unreleased datasets, such as the CDC's V-safe monitoring system reports on adverse events, revealing patterns of underreporting and health impacts that challenge official narratives on . The organization's activities extend to public education via resources like scientific analyses, legal updates, and media production, including Bigtree's platform The HighWire, which disseminates findings from obtained documents to highlight discrepancies between regulatory claims and on risks such as autoimmune disorders, neurological effects, and outcomes associated with . Notable achievements include forcing HHS to concede the absence of comprehensive studies as mandated under the of 1986, and recent petitions demanding on updated approvals from manufacturers like and . While ICAN's data-driven advocacy has amplified calls for amid rising vaccine injury reports and eroded in authorities—particularly following the rapid deployment of countermeasures without long-term trials—it has drawn opposition from pharmaceutical interests and establishments, which frequently characterize the group as oppositional to rather than focused on verifiable . Funded primarily through donations, ICAN reported revenues exceeding $20 million in recent years, enabling sustained litigation and outreach to support affected individuals and policy reform.

Founding and History

Establishment and Early Development

The Informed Consent Action Network (ICAN) was established in 2016 as a non-profit organization by , a television producer with prior experience on CBS daytime programs including The Doctors, for which he received an Emmy Award. Bigtree's involvement in vaccine-related issues began with his production of the 2016 documentary Vaxxed: From Cover-Up to Catastrophe, which centered on claims by CDC whistleblower William Thompson alleging omission of data linking the to risk in certain populations. ICAN's founding was driven by Bigtree's assessment of deficiencies in safety protocols, including the lack of large-scale, placebo-controlled trials for many and inadequate long-term monitoring of adverse events post-licensure. The organization aimed to address these through demands for transparency in government-held data, rooted in the principle that individuals require verifiable evidence of and efficacy to exercise prior to medical procedures like . In its early phase, ICAN structured itself around legal advocacy to compel federal agencies such as the Department of Health and Human Services and the CDC to release raw safety data via mechanisms like Act requests, positioning the group as a counter to perceived regulatory opacity rather than outright opposition to vaccines. This approach emphasized empirical scrutiny over policy mandates, with initial resources directed toward public education on data gaps rather than broad anti-vaccination campaigns.

Key Milestones and Expansion

In October 2017, ICAN dispatched a letter to the U.S. Department of Health and Human Services (HHS) seeking documentation of safety surveillance, specifically the biennial reports to required under the 1986 to assess adverse events and program efficacy. Following an initial FOIA request in August 2017 and subsequent litigation, HHS stipulated in a 2018 settlement that no such reports had been filed since the Act's enactment. ICAN's activities intensified during the from 2020 to 2023, with multiple FOIA requests targeting data for emergency-use-authorized , including details on controls and post-marketing safety surveillance. These pursuits, alongside petitions challenging vaccine labeling omissions, amplified ICAN's role in amid heightened public scrutiny of regulatory processes. By 2025, ICAN broadened its regulatory engagements beyond vaccines, submitting a citizen petition to the FDA on urging revised labeling for acetaminophen products to highlight risks of neurodevelopmental disorders from prenatal exposure, supported by epidemiological studies associating prolonged use with elevated odds of disorder and ADHD in offspring. In September 2025, ICAN facilitated a Permanent Subcommittee on Investigations hearing on safety science, spotlighting unpublished research on chronic illness disparities between vaccinated and unvaccinated populations to press for data release and . These initiatives marked ICAN's evolution toward influencing broader pharmaceutical oversight and legislative inquiries.

Leadership and Organizational Structure

Del Bigtree's Role

, an Emmy Award-winning , transitioned from to vaccine advocacy following his work on health segments for the show The Doctors, where he produced a 2011 episode scrutinizing the safety of the , prompting his deeper examination of pharmaceutical influences on narratives. This experience fueled his toward regulatory assurances, leading him to produce the 2016 documentary Vaxxed: From Cover-Up to Catastrophe, which centered on claims by CDC scientist William Thompson that agency officials omitted data from a 2004 study suggesting a higher risk in African American boys receiving the before 36 months of age. The film, directed by , amplified these whistleblower allegations and positioned Bigtree as a prominent critic of vaccine development . In 2016, Bigtree founded the Informed Consent Action Network (ICAN) and assumed the role of CEO, applying his production expertise to craft media strategies that emphasize data-driven challenges to safety claims through accessible formats like investigative and visual . His leadership has integrated public education efforts, including hosting The Highwire, a weekly show that dissects regulatory documents and scientific studies to highlight potential oversight failures in and drug approval processes. This approach has established him as a leading voice in risk awareness, prioritizing empirical scrutiny of data over institutional endorsements. Bigtree's influence extends to alliances with figures advocating medical autonomy, notably serving as communications director for 's 2024 presidential campaign, where he shaped messaging against coercive vaccination policies. These ties have reinforced ICAN's focus on opposing mandates, framing them as infringements on individual consent amid revelations of regulatory inconsistencies, such as untested combinations in authorizations. Through extensive at conferences and events, Bigtree continues to mobilize discourse on causal links between interventions and health outcomes, drawing from primary records to underscore gaps in testing.

Governance and Key Personnel

The Informed Consent Action Network (ICAN) functions as a 501(c)(3) , governed by an internal executive structure rather than a publicly detailed , with operations centered on a collaborative team of approximately 20 members specializing in , , and strategic actions. This framework prioritizes cross-functional coordination among scientists, researchers, and advocates to scrutinize , contrasting with criticisms of opaque in agencies like the FDA and CDC, where internal processes have been revealed through ICAN's inquiries to lack comparable public accountability. Key personnel include Catharine Layton, who has managed legal coordination, outreach, and since 2017, supported by her certificates in immunology and infectious disease from . Other operational roles encompass a Chief Innovation Officer for campaign , a of for resource allocation, and specialized positions in and to facilitate evidence-based critiques of medical interventions. External legal support is provided by attorneys such as Aaron Siri of Siri & Glimstad LLP, who assists in Act pursuits and related operational litigation, enabling the team's data-driven challenges without embedding counsel as permanent staff. ICAN's governance model underscores transparency in resource use, directing 93% of funds toward programmatic activities like public education and data analysis, as self-reported in organizational disclosures—a practice positioned as a corrective to the non-disclosure norms observed in federal health bureaucracies. This structure fosters agility in responding to emerging safety concerns through iterative team reviews, rather than hierarchical mandates, aligning with the nonprofit's mandate for empirical accountability in consent processes.

Mission, Principles, and Focus Areas

The (ICAN) posits as an inviolable ethical and legal prerequisite for any medical intervention, emphasizing individuals' to refuse or accept procedures only after receiving exhaustive of potential risks, benefits, and alternatives. This principle derives from foundational , including the patient's right to , and aligns with constitutional safeguards in the United States, such as protections against compelled bodily intrusions under the Fourth and Fourteenth Amendments. ICAN maintains that without such transparency, consent cannot be genuinely voluntary, positioning full as a bulwark against paternalistic overreach by medical authorities or government entities. Central to ICAN's advocacy is the contention that coercive policies, including those mandating participation in programs without provisions supported by rigorous safety , erode the essence of voluntary . They argue these measures prioritize collective imperatives over personal , particularly when long-term causal effects remain unverified through independent, empirical scrutiny rather than reliance on institutional declarations. ICAN promotes a framework of causal accountability, insisting that decisions must be informed by observable on outcomes, not deferred to regulatory trust, to mitigate risks of unintended harm. In pursuing these objectives, ICAN seeks to empower patients and families by fostering a culture of toward unproven assurances, advocating instead for proactive of intervention safety profiles through accessible, unaltered . This approach underscores their commitment to eradicating "man-made disease" via heightened accountability, ensuring that processes reflect reality-based over procedural compliance.

Emphasis on Vaccine and Drug Safety

The Informed Consent Action Network prioritizes in assessing , contending that true cannot be established without randomized, placebo-controlled trials using inert placebos to isolate adverse events from background rates. ICAN has documented that no U.S.-licensed for infants and children underwent such trials prior to approval, with licensing instead based on comparisons to other or historical data lacking inert controls. In a 2018 response to ICAN's inquiry, the U.S. Department of Health and Human Services confirmed it possessed no placebo-controlled studies demonstrating the overall of the childhood . ICAN argues this evidentiary gap undermines claims of comprehensive pre-licensure , as active comparators may mask reactogenicity shared across products. ICAN extends this scrutiny to specific vaccines, including COVID-19 shots, petitioning the Food and Drug Administration in June 2021 to acknowledge the absence of inert placebo arms in pivotal trials and to require such designs for future authorizations. For updated formulations, ICAN filed Freedom of Information Act requests in August 2025 demanding all underlying safety documents relied upon by the FDA for approvals of and boosters, highlighting incomplete public disclosure of reactogenicity and long-term data. Similarly, in March 2025, ICAN interrogated the safety profiles of licensed H5N1 bird flu vaccines, revealing limited trial data and unverified claims of efficacy against circulating strains. Post-licensure systems like the receive ICAN's criticism for relying on passive, voluntary reports that signal potential harms but cannot quantify incidence or without active follow-up. ICAN maintains that authorities' admissions of data deficiencies—such as the lack of large-scale, controlled studies isolating effects from confounders—expose overreliance on observational methods prone to . Beyond , ICAN investigates pharmaceutical safety, notably petitioning the FDA on September 22, 2025, to mandate warnings on acetaminophen labels, citing over 30 studies associating prenatal exposure with elevated odds of , ADHD, and reproductive disorders in offspring. The petition references meta-analyses showing consistent dose-response patterns, arguing regulatory inaction ignores causal signals from longitudinal cohorts despite animal models demonstrating . While the FDA and manufacturers assert insufficient evidence of direct causation, ICAN emphasizes the precautionary need for labeling to enable amid unresolved epidemiological debates.

Freedom of Information Act Pursuits

The Informed Consent Action Network (ICAN) has systematically utilized Freedom of Information Act (FOIA) requests to obtain raw safety data, records, and reports from federal agencies including the Centers for Disease Control and Prevention (CDC), (FDA), Department of Health and Human Services (HHS), and (NIH). These requests target underlying agency claims on safety, such as pre-licensure studies for specific populations or mechanisms of action. By compelling responses, ICAN aims to highlight absences in foundational data, prompting agencies to acknowledge evidentiary shortcomings without relying on litigation outcomes. A notable example involves and Tdap vaccines recommended for . In 2019, ICAN's FOIA request to the FDA revealed no records of clinical trials demonstrating the safety of vaccines for this group, nor any licensing explicitly for use; the agency confirmed reliance on off-label recommendations absent supporting U.S.-based trials. Similarly, requests to the CDC for data on DTaP vaccine safety, including placebo-controlled trials or studies refuting links to conditions like , yielded responses indicating no such records existed to substantiate certain agency assertions. For vaccines, ICAN submitted targeted FOIA requests in 2020 and 2021 for biodistribution studies and mRNA persistence data, exposing gaps in domestic testing records. Agencies often responded with "no records found" for claims like rapid clearance of vaccine-induced , as in a September 2025 CDC reply confirming the absence of supporting studies. ICAN also secured raw V-Safe data from the CDC, comprising self-reported health surveys from over 10 million recipients, enabling independent analysis of post-vaccination symptoms. In August 2025, ICAN requested all FDA documents underpinning approvals for updated and vaccines, underscoring ongoing pursuits for in biodistribution and long-term metrics. These efforts have collectively documented over hundreds of such queries, systematically probing for verifiable empirical foundations in oversight.

Major Lawsuits and Petitions

In 2017, ICAN filed a against the U.S. Department of Health and Human Services (HHS) under the of 1986, which mandates biennial reports to on improvements in safety monitoring. HHS conceded in court documents filed on July 9, 2018, that it had not produced or submitted any such reports for over 30 years, despite legal requirements to assess and report on injury prevention efforts. This admission highlighted gaps in federal oversight of potential causal relationships between vaccines and adverse health outcomes, as ICAN argued the absence of reports undermined claims of robust safety surveillance. In December 2020, ICAN initiated a federal lawsuit against (Google LLC) and (Meta Platforms, Inc.), alleging illegal and First Amendment violations after the platforms terminated ICAN's accounts without prior warnings or strikes, citing content on vaccine risks during the . The suit sought restoration of the accounts and argued that the suppressed discourse on intervention-related harms, including potential vaccine side effects, in coordination with government pressures. A federal appeals court dismissed the case in February 2022, ruling the platforms' actions fell under protections, though ICAN maintained the decision overlooked evidence of viewpoint discrimination tied to narratives. ICAN pursued regulatory challenges against specific vaccine approvals, including a June 2021 against the (FDA) questioning the licensure of the , asserting that pre-licensure data failed to demonstrate risks beyond seven days post- and lacked adequate controls for long-term causal effects on . In August 2022, ICAN petitioned the FDA under 21 C.F.R. § 10.30 to revoke or suspend approval of the IPOL inactivated , citing the absence of properly randomized, placebo-controlled trials to establish and , particularly regarding risks of vaccine-derived and neurological outcomes. The petition emphasized empirical gaps in proving no causal harm from the vaccine's components, drawing on historical data showing incidence declines predating widespread . In October 2023, ICAN filed a lawsuit to invalidate key provisions of the Public Readiness and Emergency Preparedness (PREP) Act, targeting manufacturer immunity from liability for COVID-19 countermeasures and the Countermeasures Injury Compensation Program's limitations on due process and evidentiary standards for injury claims. A follow-up suit in April 2024 supported plaintiffs challenging the program's adequacy for vaccine-injured individuals, arguing it denied fair hearings and obscured causal attributions of adverse events like myocarditis. These actions collaborated with allies such as Children's Health Defense, focusing on restoring legal accountability for unproven intervention safety profiles. ICAN has also petitioned the FDA for enhanced drug warnings, such as a 2025 request to update acetaminophen labels citing studies linking prenatal exposure to neurodevelopmental risks, underscoring demands for transparency on causal mechanisms beyond acute effects. In July 2018, the U.S. Department of Health and Human Services (HHS) stipulated in Informed Consent Action Network v. HHS that it possessed no records of submitting required biennial reports to on vaccine injury compensation, vaccine supply, and improvements in vaccine safety pursuant to the of 1986 (42 U.S.C. § 300aa-27). This admission followed ICAN's Freedom of Information Act (FOIA) request and subsequent lawsuit, confirming that HHS had not fulfilled statutory monitoring obligations for over 30 years despite collecting data on vaccine-related injuries. In September 2022, a federal court ordered the Centers for Disease Control and Prevention (CDC) to release comprehensive V-safe data encompassing over 137 million health entries from users reporting symptoms following vaccination. This outcome stemmed from ICAN's litigation compelling disclosure of the previously unreleased dataset, which included free-text entries later fully mandated for production in 2024, totaling 7.8 million entries over 12 months. The released data highlighted underreported adverse events, such as systemic reactions in a significant portion of surveyed individuals, though CDC analyses maintained overall . In June 2021, the CDC conceded in response to ICAN's lawsuit that it could not produce studies supporting its public claim that vaccines do not cause autism in babies, revealing an absence of direct comparative research on the full childhood vaccine schedule versus unvaccinated populations. This outcome underscored gaps in evidentiary support for CDC assertions on vaccine safety endpoints, prompting scrutiny of Vaccine Safety Datalink (VSD) utilization, where ICAN's efforts exposed that certain datasets, including potential placebo-controlled trial records for vaccines like DTaP, had not been comprehensively analyzed or publicly detailed prior to compelled disclosures.

Funding and Financial Operations

Revenue Sources and Donors

The Informed Consent Action Network (ICAN) obtains nearly all its funding from private contributions, which accounted for $23,123,376 or 99.5% of its $23.2 million in 2023, as detailed in IRS filings. These contributions encompass one-time individual donations, recurring monthly pledges totaling over $6 million in 2022, and grants from aligned foundations, with merchandise sales contributing a minor $25,603 in the same period. ICAN discloses no revenue from grants in its , preserving operational independence in its regulatory critiques, though it accepted a forgivable loan during the 2020 economic downturn. Major funding has historically included substantial support from foundations within vaccine-skeptic networks, such as the Selz Foundation, which provided approximately three-fourths of ICAN's budget in 2019. Many contributions route through donor-advised funds, a facilitating giving often utilized by high-net-worth individuals skeptical of mainstream policies. ICAN explicitly avoids funding, consistent with its mission to challenge drug and safety oversight, and relies on public transparency via IRS-mandated disclosures rather than itemizing all donors, as Schedule B contributor details remain confidential for . This donor composition underscores ICAN's dependence on and ideologically aligned private support, with no reported ties to corporate or institutional funders outside sympathetic circles.

Financial Growth and Transparency

The Informed Consent Action Network (ICAN) reported revenue of $23 million for the fiscal year ending December 2023, reflecting a 74% increase from $13.4 million in 2022. This growth paralleled rising public interest in vaccine safety and issues amid ongoing debates over policies and mandates. Expenditures rose to nearly $17 million in 2023, a 25% increase from the prior year, with substantial allocations to legal activities, including $6 million directed to the Siri & Glimstad for litigation support. In , program services—encompassing legal pursuits, educational outreach, and advocacy—accounted for 93.6% of total expenses ($12.7 million out of $13.6 million), underscoring a focus on mission-driven operations over administrative overhead. CEO received $234,000 in compensation in 2023, a figure disclosed in IRS filings, which some critics argue warrants scrutiny relative to organizational impact, though proponents contend it reflects the demands of leading resource-intensive legal challenges. ICAN maintains financial accountability through public IRS disclosures and annual Donor Impact Reports, which break down revenue streams and expense categories, achieving a 4/4 star rating from for and . This approach stands in contrast to documented lapses in by federal agencies like the of Health and Human Services, which ICAN has litigated against for incomplete vaccine adverse event reporting under statutory mandates.

Public Advocacy and Educational Efforts

Campaigns on Vaccine Transparency

In October 2017, the Informed Consent Action Network (ICAN) launched a public campaign challenging the U.S. Department of Health and Human Services (HHS) to provide documentation proving compliance with its statutory duty under 42 U.S.C. § 300aa-27 to annually report on improvements in since 1986. The initiative highlighted alleged gaps in federal monitoring, demanding empirical evidence of safety studies, including placebo-controlled trials for pediatric , which ICAN argued were absent or inadequately conducted. HHS's subsequent response in January asserted that had been verified through clinical trials and post-licensure but provided no supporting records or data voids addressing ICAN's specific queries on tracking and causation analysis. ICAN followed with a detailed refutation, publicly disseminating the correspondence to underscore the lack of verifiable proof for claims of comprehensive safety oversight, such as the absence of studies isolating ingredients' effects or long-term data against evolving strains. This effort extended to media amplification via platforms like The Highwire, where ICAN representatives critiqued federal assertions of robust monitoring systems like VAERS, citing underreporting rates estimated at less than 1% of serious events based on historical surveys. Complementing these advocacy letters, ICAN has released FOIA-obtained datasets to educational resources, including V-safe free-text entries from over 10 million recipients documenting symptoms like cardiac issues and neurological effects not reflected in aggregated CDC summaries. Similarly, disclosures of lot-specific data for vaccines like revealed variability in reported adverse events, prompting campaigns questioning uniformity in manufacturing quality and risk profiles. In August 2025, ICAN reiterated these transparency demands by submitting FOIA requests for all raw safety documents underlying FDA approvals of updated and vaccines, arguing that partial releases obscured potential causal links to observed health declines.

Broader Public Engagement Initiatives

The Informed Consent Action Network maintains an online platform featuring educational resources aimed at empowering individuals to make autonomous decisions, including white papers and summary charts on regulatory and . These materials emphasize scrutiny of environmental and pharmaceutical influences on , extending beyond specific interventions to broader inquiries into , air, water, and drug quality. ICAN produces content to foster public discourse on causal factors in outcomes, such as the 2025 documentary An Inconvenient Study, which examines unpublished research on chronic disease links to early-life exposures and has prompted global discussions on evidence-based . Complementing this, the organization's affiliated The HighWire talk show, hosted by founder , reaches over 4.5 million viewers weekly across more than 190 countries, disseminating data-driven analyses to challenge institutional narratives that downplay potential adverse effects of policies. Through these channels, ICAN promotes tools for personal agency, including downloadable presentations on exemption strategies and regulatory oversight, encouraging community-level evaluation of health authority claims against empirical records. This outreach prioritizes transparency in decision-making processes, positioning individuals as primary evaluators of multifaceted health risks rather than passive recipients of expert consensus.

Reception, Controversies, and Debates

Achievements and Supporter Perspectives

ICAN's legal efforts have compelled federal agencies to disclose the absence of certain studies, which supporters cite as empirical validations of oversight failures. In a July 9, 2018, stipulation resulting from ICAN's lawsuit against the U.S. Department of Health and Human Services (HHS), the agency admitted it had not produced or submitted any biennial reports to on injury prevention or improvements since the 1986 required them every two years. Proponents regard this concession as exposing a 30-year regulatory lapse in mandated monitoring, thereby enabling public examination of unverified assumptions underlying policies. Further disclosures obtained via ICAN's litigation include the Centers for Disease Control and Prevention's (CDC) March 2020 stipulated order acknowledging no existing studies assessing whether vaccines routinely given to infants in their first six months—such as DTaP, , Hib, PCV13, and IPV—do not cause . In 2020, the (NIH) similarly conceded a lack of studies on the safety of aluminum adjuvants in infant vaccines. Advocates interpret these admissions as concrete proof of evidentiary voids in foundational safety claims, facilitating informed decision-making by highlighting reliance on incomplete data rather than comprehensive trials. ICAN's Freedom of Information Act pursuits have also yielded raw datasets for independent review, including over 137 million health entries from the CDC's V-safe app monitoring recipients, released after multiple lawsuits and encompassing free-text reports of adverse events. Supporters praise this as a triumph in , arguing it arms individuals with unfiltered evidence of post-vaccination experiences, countering opaque regulatory narratives and promoting accountability. From the perspective of ICAN's backers, these victories establish the organization as a defender of rights, using judicial mechanisms to unearth systemic deficiencies that erode trust in health authorities. They contend that such data-driven revelations justify skepticism toward consensus-driven endorsements, framing as an evidence-based stance responsive to demonstrable gaps in verification processes.

Criticisms from Mainstream and Regulatory Bodies

Mainstream media outlets have accused the Informed Consent Action Network (ICAN) of functioning as an anti-vaccination organization that sows through aggressive legal campaigns, particularly by capitalizing on public fears over mandates to deter uptake. For instance, reporting in highlighted ICAN's series of lawsuits and petitions as efforts to undermine efforts amid the , framing such actions as part of a broader strategy to erode trust in regulatory approvals. These portrayals often equate ICAN's demands for transparency on safety data—such as placebo-controlled trials—with outright opposition to , without directly addressing the empirical gaps in historical testing records that ICAN's inquiries have spotlighted. Legal scholars have critiqued ICAN's approach to Act (FOIA) requests and litigation as a mechanism to spin false narratives, alleging that the organization misrepresents agency responses and court to imply systemic concealment of risks. A 2022 analysis in the Northwestern Journal of and Social Policy examined cases like ICAN's 2017 FOIA lawsuit against the Department of Health and Human Services (HHS), where a of dismissal was portrayed by ICAN as an admission of no efforts, despite prior agency reports documenting such activities. Similarly, in a 2019 FOIA suit against the Centers for Disease Control and Prevention (CDC) regarding studies on , the CDC provided references to existing , yet ICAN claimed this as of absent , a tactic described as reinforcing preconceived anti- beliefs rather than yielding verifiable new insights. Critics contend this pattern prioritizes in-group mobilization and talking points over substantive legal victories, contributing to by amplifying distrust without empirical refutation of the queried voids. Regulatory bodies such as the (FDA) and CDC have countered ICAN's petitions and suits through denials and court defenses emphasizing established safety protocols, viewing the inquiries as attempts to challenge via procedural maneuvers. For example, the FDA rejected ICAN's 2020 citizen petition on the , asserting that the requested long-term data was unnecessary given post-authorization surveillance systems like VAERS, which track adverse events without confirming in isolation. In related litigation, such as ICAN v. NIH (2020), agencies released datasets on trials but maintained that ICAN's interpretations ignored broader from observational studies and meta-analyses, framing the disputes as distractions from proven risk-benefit profiles rather than genuine deficits. These institutional responses often dismiss ICAN's focus on causal links—such as unaddressed potential for vaccine-induced conditions—as unfounded, prioritizing population-level efficacy data over individualized risk inquiries. Critiques have also targeted ICAN's financial ties to figures like and organizations such as (CHD), portraying these as conduits for anti-vaccine funding that amplify legal activism without rigorous scientific backing. Reporting in late 2024 noted ICAN's revenue surge to $23 million in , attributing much of the growth to donors aligned with Kennedy's network, which mainstream sources link to promotion of about harms. Such associations are cited as evidence of coordinated efforts to foster hesitancy, with detractors arguing that resources funneled through these channels support narrative-driven lawsuits over evidence-based advocacy, though the funding enables FOIA successes revealing regulatory admissions of data limitations.

Ties to Broader Movements

The Informed Consent Action Network (ICAN) maintains alliances with key figures and organizations in the vaccine transparency and health policy reform movements, including attorney Aaron Siri and Robert F. Kennedy Jr. (RFK Jr.). Siri, through his firm Siri & Glimstad LLP, has represented ICAN in numerous Freedom of Information Act (FOIA) lawsuits and regulatory petitions since at least 2017, securing disclosures of vaccine safety data from federal agencies. These efforts align with Siri's advisory role to RFK Jr. on health policy, including petitions filed on ICAN's behalf, such as a 2022 request to the FDA to revoke approval of the oral polio vaccine due to alleged safety risks. ICAN's executive director, Del Bigtree, has collaborated with RFK Jr.-led initiatives, including public calls in August 2025 for reforms to curb pharmaceutical industry influence on the CDC's Advisory Committee on Immunization Practices (ACIP). This partnership extends to overlaps with the "Make America Healthy Again" (MAHA) agenda, where ICAN's transparency goals intersect with RFK Jr.'s focus on chronic disease prevention and regulatory overhaul following his 2025 appointment as HHS Secretary. ICAN also operates within a network including Children's Health Defense (CHD), RFK Jr.'s former organization, sharing objectives in challenging vaccine mandates through litigation and advocacy, as seen in coordinated resistance to school requirements during the COVID-19 era. These ties have amplified ICAN's legal and empirical challenges to policies but sparked debates over potential conflicts, particularly regarding litigation and . Critics, including outlets, highlight ethical concerns about Siri's dual roles in suing regulators while advising HHS, potentially blurring lines between and . Proponents argue such collaborations prioritize data-driven over institutional , countering claims of bias by emphasizing verifiable FOIA outcomes rather than partisan narratives. characterizations often frame these networks as "anti-," though ICAN's work centers on and mandates, not outright opposition.

Impact on Policy and Public Discourse

Influences on Government Accountability

In 2018, the Informed Consent Action Network (ICAN) filed a lawsuit against the U.S. Department of Health and Human Services (HHS) under the Freedom of Information Act, seeking biennial reports mandated by the National Childhood Vaccine Injury Act of 1986 (42 U.S.C. § 300aa-27), which required HHS to submit evidence to Congress on improvements in vaccine safety surveillance and injury compensation. HHS conceded in a July 9, 2018, court filing that no such reports had been produced or submitted since the law's enactment, admitting a failure to meet statutory accountability obligations spanning over three decades. This disclosure prompted congressional inquiries and public scrutiny of federal vaccine monitoring gaps, including subsequent demands for internal HHS reviews of adverse event reporting systems like VAERS, though HHS maintained that safety efforts continued through other channels. ICAN's FOIA litigation against the Centers for Disease Control and Prevention (CDC) yielded significant data releases, such as the 2022 court-ordered disclosure of V-safe app entries encompassing over 137 million health surveys from recipients, revealing patterns of reported adverse events including hospitalizations and life-threatening conditions that had not been proactively analyzed or publicized by the agency. Similarly, suits against the (NIH) compelled revisions to redacted trial documents, exposing limitations in preclinical biodistribution studies where lipid nanoparticles were shown to accumulate in organs like the liver, ovaries, and rather than remaining localized at injection sites—data not fully detailed in initial regulatory approvals. These outcomes pressured CDC and NIH to acknowledge surveillance shortcomings, including the absence of long-term placebo-controlled trials for certain vaccine safety claims, fostering demands for enhanced causal tracking of potential adverse outcomes beyond immediate post-vaccination periods. ICAN's petitions to the (FDA) have influenced ongoing debates over vaccine labeling and approval transparency, such as 2021-2022 requests for records supporting claims that vaccines do not alter DNA or interact with genetic material, which highlighted regulatory reliance on manufacturer-submitted data without independent verification of key mechanisms like reverse transcription risks. In 2025, ICAN's FOIA demands for full safety dossiers on updated and vaccines underscored gaps in pregnancy-related testing and biodistribution modeling, contributing to FDA reconsiderations of warning labels and post-market surveillance protocols to better reflect empirical risks over assumptive safety profiles. These efforts have causally linked advocacy to procedural shifts, including accelerated data unredactions and petitions prompting FDA acknowledgments of incomplete datasets, thereby elevating requirements for verifiable evidence in regulatory decision-making.

Effects on Vaccine Policy and Awareness

ICAN's advocacy has influenced discussions on mandates, particularly by underscoring gaps in processes during policy formulations for school requirements and responses. For instance, in 2021 legislative hearings on mandates, witnesses emphasized personal and consent voids, contributing to debates that questioned blanket enforcement without robust safety data transparency. ICAN supported such discourse through educational materials, including a 2024 presentation detailing state-specific childhood mandates and exemption strategies, which aimed to empower individuals against perceived overreach. The organization has heightened public awareness of limitations in surveillance, notably underreporting in VAERS. In April 2021, ICAN corresponded with CDC's Immunization Safety Office, citing empirical evidence that serious injuries from vaccines, including shots, were significantly underreported—potentially by factors exceeding 10-fold based on prior studies like the 2010 Harvard Pilgrim analysis. This push challenged prevailing media and regulatory assurances of comprehensive monitoring, prompting calls for mandatory reporting protocols and independent validation of safety claims, as VAERS relies on voluntary submissions prone to incomplete capture. Federal reviews, such as those by of Medicine, have corroborated VAERS's inherent under-detection of events, estimating it signals only a fraction of occurrences. Over time, ICAN's efforts have spurred broader empirical scrutiny of vaccine policies, framing not as irrational but as a rational response to evidentiary shortfalls in long-term safety data. By disseminating analyses via platforms like The Highwire, ICAN has amplified demands for reformed , including proactive government studies on cumulative effects, potentially influencing future policy toward enhanced pre-mandate mechanisms and decentralized research. This has coincided with observed rises in public demand for amid rollout debates, where initial policy rigidities faced pushback linked to unverified risk-benefit assertions.

References

  1. [1]
    About Us - ICAN - Informed Consent Action Network
    Founded in 2016, ICAN was created with the goal of providing every person with the right to informed consent.
  2. [2]
    Informed Consent Action Network - GuideStar Profile
    Mission. INVESTIGATING THE SAFETY OF MEDICAL PROCEDURES, PHARMACEUTICAL DRUGS, AND VACCINES WHILE ADVOCATING FOR A PERSON'S RIGHT TO "INFORMED CONSENT".Missing: founding | Show results with:founding
  3. [3]
    [PDF] Informed Consent Action Network - Supreme Court
    Feb 5, 2024 · ICAN has been instrumental in demanding accountability for government narratives regarding vaccines and drugs through various successful.<|separator|>
  4. [4]
    V-Safe Data - ICAN - Informed Consent Action Network
    Find the interactive V-Safe dashboards below and click the DOWNLOAD buttons to obtain exclusive data obtained by ICAN.
  5. [5]
    Del Bigtree - ICAN - Informed Consent Action Network
    He is the founder of the non-profit, Informed Consent Action Network, and host of a rapidly growing internet talk show The HighWire, boasting over 33 million ...
  6. [6]
    Get Informed - ICAN
    Use the filter to search ICAN's library of lawsuits, FOIA's, legal letters, scientific and educational resources
  7. [7]
    ICAN Demands Full Transparency on Safety Data for Latest ...
    Aug 27, 2025 · FDA approved new COVID vaccines from Moderna and Novavax in May. ICAN is submitting FOIA requests to FDA for all documents relied upon to ...<|control11|><|separator|>
  8. [8]
    [PDF] Donor Impact Report 2023 - Informed Consent Action Network
    Founded in 2016, ICAN was created to educate all individuals on their right to informed consent. We believe that by holding.
  9. [9]
    Prose, Poetry & Purpose – Del Bigtree – Voice of Vashon
    Del Bigtreewas an Emmy Award-winning producer on the daytime talk show The Doctors, for six years. With a background both as a filmmaker and an investigative ...
  10. [10]
  11. [11]
    Vaccine Safety Debate - ICAN - Informed Consent Action Network
    In October 2017, ICAN sent HHS a letter demanding that it explain serious and dangerous shortcomings in vaccine safety. The health agencies responded by ...Missing: monitoring | Show results with:monitoring
  12. [12]
    [PDF] HHS-Response-1.pdf - Informed Consent Action Network
    I am proud to report that data show the United States currently has the safest supply in history. I have provided responses to your specific questions in ...
  13. [13]
    ICAN Petitions to FDA Regarding COVID-19 Vaccines
    Jun 3, 2021 · When clinical trials for the COVID-19 vaccines were released (and did not include an inert placebo), ICAN filed a forceful petition ...
  14. [14]
    COVID vaccine FOIA denial requests - ICAN
    Jun 3, 2021 · ICAN is a 501(c)(3) organization. Donations to ICAN are tax-deductible. ICAN Legislate is a 501(c)(4) and the political arm of ICAN. Donations ...
  15. [15]
    ICAN Brings Lawsuit Related to “Placebo” in COVID-19 Clinical Trial
    Jun 3, 2021 · Donations to ICAN Legislate are not tax-deductible. Donate By Mail. Informed Consent Action Network P.O. Box 131568. Houston, TX 77219-1568 ...
  16. [16]
    ICAN Submits Petition to Ensure FDA Changes Acetaminophen ...
    Oct 6, 2025 · ICAN's petition contains a comprehensive overview of the scientific evidence linking frequent acetaminophen use during pregnancy to fetal ...Missing: 2024 | Show results with:2024
  17. [17]
    Del Bigtree and ICAN Announce Senate Hearing on Science and ...
    Sep 9, 2025 · WASHINGTON, DC, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Informed Consent Action Network (ICAN), led by Emmy Award-winning producer and ...
  18. [18]
    [PDF] Siri-Testimony-1.pdf
    Sep 5, 2025 · injuries pharma companies have a basis to conclude are caused by their vaccines have barely been studied; the CDC's supposed vaccine safety ...Missing: 2024-2025 | Show results with:2024-2025
  19. [19]
    [PDF] Who Is Del?
    Jan 25, 2021 · Del Bigtree is one of the preeminent voices of the Vaccine Risk Awareness Movement. His career as an Emmy ... Vaxxed: From Cover-up to Catastrophe ...
  20. [20]
    Vaxxed: From Cover-Up to Catastrophe (2016) - IMDb
    Vaxxed: From Cover-Up to Catastrophe: Directed by Andrew Wakefield. With Del Bigtree, Mark F. Blaxill, Michaela Blaxill, Baxter Burrowes.
  21. [21]
    [PDF] The Facts Behind the “CDC Whistleblower” Accusations Spotlighted ...
    In August 2014, anti-vaccine activists Brian Hooker and Andrew Wakefield released a video of recorded phone conversations with an individual named as Dr.
  22. [22]
    RFK Jr. hires Del Bigtree, top anti-vaccine activist, as campaign ...
    Jan 2, 2024 · Robert F. Kennedy Jr. hired Del Bigtree, who leads ICAN, a top anti-vaccine organization, as his presidential campaign's communications ...Missing: background | Show results with:background
  23. [23]
    Anti-vaccine group with ties to RFK Jr. saw another windfall last year ...
    Dec 23, 2024 · Del Bigtree's Informed Consent Action Network, which advocates against polio, measles, hepatitis and Covid vaccines, brought in $23 million ...
  24. [24]
    Del Bigtree - The WAVE
    Speaking at The WAVE, Del Bigtree is an Emmy Award-winning television and film producer and leading voice in the medical freedom movement.Missing: background | Show results with:background
  25. [25]
    [PDF] Case 1:21-cv-04134 Document 1 Filed 05/07/21 Page 1 of 52
    3. The Informed Consent Action Network (“ICAN”) is an organization dedicated to improving vaccine safety through, inter alia, investigating and disseminating ...
  26. [26]
    Team Members Archive - ICAN - Informed Consent Action Network
    Catharine Layton. Catharine Layton serves as Chief Operating Officer of the Informed Consent Action Network (ICAN), the nation's leading public health watchdog.Missing: governance | Show results with:governance
  27. [27]
    Resistance to vaccine mandates is building. A powerful network is ...
    May 26, 2021 · The Informed Consent Action Network, a Texas-based nonprofit group ... Siri & Glimstad's managing partner, Aaron Siri. “Employers and ...
  28. [28]
    [PDF] Case 1:19-cv-11947 Document 1 Filed 12/31/19 Page 1 of 36
    Plaintiff, Informed Consent Action Network, is a not-for-profit organization with an office located at 140 Broadway, 46th Floor, New York, New York 10005. 16.
  29. [29]
    [PDF] NO Placebo
    Oct 18, 2023 · Note that to license a vaccine for children, the FDA relies upon the clinical trial conducted with children, not adults, because as the FDA ...<|separator|>
  30. [30]
    ICAN Attorneys Demand Answers on Bird Flu Vaccines
    Mar 11, 2025 · As bird flu (H5N1) continues to receive public attention, ICAN investigated the three U.S. licensed H5N1 vaccines.
  31. [31]
    [PDF] Page 1 of 42 October 17, 2025 By Electronic Submission ... - Kenvue
    Oct 17, 2025 · ... Informed Consent Action Network, Dkt. No. FDA-2025-. P-4153 (Sept. 22 ... 30 CDER, Epidemiology Review of Study on Acetaminophen Use in Pregnancy ...
  32. [32]
  33. [33]
    Stipulated Order Showing FDA's Off-Label Use of Vaccines During ...
    Nov 3, 2019 · Upon investigation, ICAN determined the FDA has not licensed any influenza vaccine as an indicated use for pregnant women, ...
  34. [34]
    [PDF] CDC Concedes in Federal Court It Does Not Have Studies to ...
    Mar 5, 2020 · The FDA, pursuant to a FOIA request from ICAN, eventually produced the clinical trials it relied upon to license the current MMR vaccine which ...
  35. [35]
    [PDF] Research and Findings on Efficacy of DTP
    Mar 5, 2020 · Despite months of demands, the CDC failed to produce a single specific study in response to these FOIA requests. ICAN was therefore forced to ...<|control11|><|separator|>
  36. [36]
    Segment 3: CDC Unable to Support Claim that COVID-19 Vaccine ...
    Sep 10, 2025 · “No Records Found” – Segment 3: CDC Unable to Support Claim that COVID-19 Vaccine Spike Protein is Quickly Cleared from the Body. Because of ...
  37. [37]
    ICAN FILES OPPOSITION TO FACEBOOK AND YOUTUBE'S ...
    Jun 26, 2021 · ICAN, through its attorneys, sued YouTube and Facebook at the end of last year for wrongfully and illegally terminating ICAN's YouTube ...
  38. [38]
    Another Anti-Vaxxer Jawboning Lawsuit Fails-ICAN v. YouTube
    Feb 5, 2022 · ICAN sued YouTube and Facebook for violating its First Amendment rights and sought must-carry relief “ordering Defendants to restore ICAN's accounts.
  39. [39]
    ICAN v. FDA – Hepatitis B Vaccine Should Never Have Been Licensed
    Jun 3, 2021 · ICAN's attorneys therefore filed a lawsuit against the FDA to obtain clinical trials that show safety was reviewed for more than 7 days before ...<|separator|>
  40. [40]
    [PDF] Petition-IPOL-2022-08-23.pdf - Informed Consent Action Network
    This petition is being submitted pursuant to 21 C.F.R. § 10.30 and related relevant provisions of the Federal Food, Drug, and Cosmetic Act and Public Health ...
  41. [41]
    ICAN's Attorneys File Major Lawsuit to Strike Down Portions of The ...
    Oct 10, 2023 · ICAN has filed a lawsuit to strike down immunity to liability and the Countermeasures Injury Compensation Program provisions of the PREP ...
  42. [42]
    ICAN's Attorneys File a Second CICP Lawsuit to Demand Justice for ...
    Apr 30, 2024 · ICAN is supporting another lawsuit challenging the Countermeasures Injury Compensation Program (CICP), filed this week in Texas.
  43. [43]
    [PDF] 42 USCS § 300aa-27 - Informed Consent Action Network
    WHEREAS, on June 27, 2018, HHS sent ICAN the following response to the FOIA. Request: The [Department]'s searches for records did not locate any records.
  44. [44]
    ICAN Obtains Court Order Requiring CDC to Release V-Safe Data ...
    Sep 15, 2022 · Breaking News: ICAN Obtains Court Order Requiring CDC to Release V-Safe Data that Includes Over 137 Million Health Entries Made After COVID-19 ...
  45. [45]
    BREAKING: Federal Judge Orders CDC to Release All V-safe Free ...
    Jan 11, 2024 · A federal judge has ordered the CDC to release all 7.8 million v-safe free text field entries over the next 12 months.
  46. [46]
    CDC Cannot Support its Claim That “Vaccines Do Not Cause Autism ...
    Jun 3, 2021 · ICAN v. CDC – CDC Fails to Produce Studies to Support the Claim that “Vaccine Do Not Cause Autism” for Vaccines Given to Babies During the ...
  47. [47]
    CDC Concedes Never Conducted Vaccinated v. Unvaccinated Study
    Jun 3, 2021 · The CDC finally conceded that it could not find a single study comparing health outcomes between vaccinated and unvaccinated children.
  48. [48]
    Informed Consent Action Network - Nonprofit Explorer - News Apps
    Summary charts: organization finances over time · Revenue. $23.2M (2023) · Expenses. $16.9M (2023) · Total Assets. $12.6M (2023) · Total Liabilities. $924k (2023).
  49. [49]
    Texas-based anti-vaccine group received federal bailout funds in ...
    Jan 18, 2021 · The Austin-based group founded by anti-vaccine activist Del Bigtree regularly posts information questioning the safety of the coronavirus ...Missing: 2016 | Show results with:2016<|separator|>
  50. [50]
    Meet the New York couple donating millions to the anti-vax movement
    Jun 19, 2019 · The Selz Foundation provides roughly three-fourths of the funding for the Informed Consent Action Network, a three-year-old charity that ...
  51. [51]
    Anti-vaxxers are now a modern political force - Politico
    Sep 24, 2023 · Most of the donations to the Informed Consent Action Network documented in tax documents are through donor-advised funds, a setup often used by ...
  52. [52]
    Informed Consent Action Network (ICAN) - InfluenceWatch
    The Informed Consent Action Network (ICAN) is a nonprofit organization that intends to provide every individual with the right to informed consent regarding ...
  53. [53]
    Rating for Informed Consent Action Network - Charity Navigator
    Rating 4/4 · Review by Charity Navigator350k donors have given $300M+ to charities via Charity Navigator. Donate easily, safely, and even anonymously today!
  54. [54]
    [PDF] HHS Vaccine Safety Responsibilities and Notice Pursuant to 42 ...
    For example, the first HHS vaccine committee (ACIP) meeting that ICAN attended began with an honorary ceremony in which ACIP announced it had engraved the name ...
  55. [55]
    ICAN Submits Point-by-Point Refutation and Notice of HHS's ...
    Jan 31, 2019 · This letter exchange between ICAN and HHS provides a comprehensive debate concerning vaccine safety with the government agency responsible for vaccine safety.Missing: monitoring | Show results with:monitoring
  56. [56]
  57. [57]
    ICAN vs. HHS: Key Legal Win Recasts Vaccine Debate - BioSpace
    Sep 14, 2018 · ICAN sued HHS in the U.S. District Court for the Southern District of New York, demanding that the reports be shared with the public. HHS ...
  58. [58]
    Stipulated Order Proving CDC Has No Studies To Support Claim ...
    Mar 5, 2020 · The CDC conceded, in court, to ICAN's requests and suits, that that it has no studies to support that any of these vaccines do not cause ...Missing: measles | Show results with:measles
  59. [59]
    Anti-vax group mounts legal blitz to sow disinformation against ...
    Jun 22, 2021 · Texas group the Informed Consent Action Network has capitalized on fear surrounding supposed vaccine mandates.
  60. [60]
    [PDF] How Anti-Vaccine Groups Use the Law to Help Spin a False Narrative
    Nov 23, 2022 · In this Article, we examine one influential anti-vaccine organization, the. Informed Consent Action Network (ICAN), that uses its far-reaching ...
  61. [61]
    Informed Consent Action Network v. FDA, No. 20-689, 2022 WL ...
    Mar 28, 2022 · 20-689, 2022 WL 902083 (S.D.N.Y. Mar. 28, 2022) (Nathan, J.) Re: Request for records concerning particular vaccine trials. Disposition: Granting ...Missing: raw | Show results with:raw
  62. [62]
    Informed Consent Action Network v. National Institutes of Health
    The Network for Public Health Law monitors key court cases and relevant judicial trends in public health. The Network's monthly reporter, Judicial Trends in ...
  63. [63]
    How RFK Jr.'s nonprofit uses legal tools to fight vaccines : NPR
    Dec 4, 2024 · The nonprofit Children's Health Defense that Kennedy led has filed nearly 30 federal and state lawsuits since 2020, many challenging ...
  64. [64]
    [PDF] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ...
    The information ICAN seeks is simply too important to the current public discourse regarding the COVID-19 pandemic to allow NIH to withhold such information ...Missing: lawsuit | Show results with:lawsuit<|separator|>
  65. [65]
    RFK Jr key adviser petitioned regulators to revoke approval of polio ...
    Dec 13, 2024 · The New York Times report noted that Siri filed the 2022 petition on behalf of ICAN calling for the FDA to revoke approval for Ipol, the only ...
  66. [66]
    RFK Jr.'s lawyer and top ally asked FDA to revoke approval of a ...
    Dec 13, 2024 · Robert F. Kennedy Jr.'s personal attorney previously petitioned the Food and Drug Administration to revoke its approval of a polio vaccine.
  67. [67]
    ICAN Calls On RFK Jr. to Take Further Action to Rein in Flagrant ...
    Aug 29, 2025 · While HHS Secretary Robert F. Kennedy Jr. recently prohibited these ... © 2025 ICAN Informed Consent Action Network. All rights ...
  68. [68]
    Kennedy's 'MAHA transition team' includes anti-vax activists - Politico
    Nov 22, 2024 · Robert F. Kennedy Jr. is enlisting associates with close ties to anti-vaccine organizations to help vet and interview candidates for senior roles.
  69. [69]
    Kennedy's Ties to Ally Leading Vaccine Lawsuits Raise Ethical ...
    Oct 6, 2025 · Aaron Siri is leading legal efforts on policies that dovetail with ... Informed Consent Action Network, or ICAN, a nonprofit run by Del ...Missing: governance | Show results with:governance
  70. [70]
    Lawyer who represented RFK Jr., anti-vaccine ... - West Virginia Watch
    Lawyer who represented RFK Jr., anti-vaccine group represents plaintiffs in WV vaccine lawsuit. By: Lori Kersey - September 25, 2025 6:00 am.Missing: 2024 | Show results with:2024
  71. [71]
    [PDF] Case 1:18-cv-03215-JMF Document 18 Filed 07/09/18 Page 1 of 3
    Jul 9, 2018 · ICAN was therefore forced to file a lawsuit to force HHS to either provide copies of its biennial vaccine safety reports to Congress or admit it ...
  72. [72]
    Vaccine Safety Debate - ICAN - Informed Consent Action Network
    Jun 3, 2021 · In October 2017, ICAN sent HHS a letter demanding that it explain serious and dangerous shortcomings in vaccine safety.
  73. [73]
    INFORMED CONSENT ACTION NETWORK v. CENTERS FOR ...
    INFORMED CONSENT ACTION NETWORK v. CENTERS FOR DISEASE CONTROL AND ... CDC and the HHS under FOIA, 5 U.S.C. § 552. See generally Compl.; see also Pl ...
  74. [74]
    Personal rights over public Health: Anti-vaccine rhetoric in the Texas ...
    Feb 28, 2024 · This paper reviewed Texas hearings on vaccine requirements and data transparency. In five hearings during 2021, 84 witnesses made 102 ...Missing: influences | Show results with:influences
  75. [75]
    Vaccine Mandates and Vaccine Exemptions Presentation - ICAN
    Sep 13, 2024 · ICAN's attorneys have put together a presentation concerning childhood vaccine mandates and exemptions that we welcome you to review, use, and ...<|separator|>
  76. [76]
    ICAN EDUCATES REPRESENTATIVE OF THE IMMUNIZATION ...
    Apr 20, 2021 · ICAN, through its attorneys, has written to Dr. Jeffery Duffy, who works for the CDC's Immunization Safety Office, to point out evidence ...
  77. [77]
    UNDERREPORTING OF SERIOUS INJURIES TO VAERS ...
    Apr 5, 2021 · ICAN, through its attorneys, has once again written to Dr. Rochelle Walensky, the new Director of the CDC, this time to demand an answer as ...
  78. [78]
    Demand to Fix VAERS - ICAN - Informed Consent Action Network
    Jun 4, 2021 · ICAN's letters with the CDC, FDA and HHS regarding requiring COVID-19 vaccine injuries be reported to VAERS.
  79. [79]
    Improving Detection of and Response to Adverse Events - NCBI - NIH
    VAERS, LLDB, vaccine manufacturer surveillance measures, and FDA response procedures have several limitations. Speakers and participants voiced several ...